文献速递肝病消化道肿瘤与早癌

全球肝病负担:2023年更新

Global burden of liver disease: 2023 update.
PubMed 文献 · J Hepatol · 2023-03-27

约三分之二的肝病相关死亡发生在男性,主要死因为肝硬化并发症和肝细胞癌。本次更新聚焦酒精相关性肝病、非酒精性脂肪性肝病、病毒性肝炎和肝细胞癌,并单独讨论非洲的肝病负担。

要点

  • 约三分之二肝病相关死亡发生在男性,主要归因于肝硬化并发症和肝细胞癌。
  • 全球肝硬化最常见病因与病毒性肝炎、酒精和非酒精性脂肪性肝病相关。

核心结论

  • 死亡主要归因于肝硬化并发症和肝细胞癌,急性肝炎占比较小。

研究设计与样本

  • 本文为全球肝病负担2019年版的更新,主要聚焦酒精相关性肝病、非酒精性脂肪性肝病、病毒性肝炎和肝细胞癌等有重要新信息的领域,并单独设节讨论非洲肝病负担。

主要发现

  • 全球肝硬化最常见病因与病毒性肝炎、酒精和非酒精性脂肪性肝病相关。
  • 嗜肝病毒是大多数急性肝炎的病因,但药物性肝损伤日益占显著比例。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Liver disease accounts for two million deaths annually and is responsible for 4% of all deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related deaths occur in men. Deaths are largely attributable to complications of cirrhosis and hepatocellular carcinoma, with acute hepatitis accounting for a smaller proportion of deaths. The most common causes of cirrhosis worldwide are related to viral hepatitis, alcohol, and non-alcoholic fatty liver disease. Hepatotropic viruses are the aetiological factor in most cases of acute hepatitis, but drug-induced liver injury increasingly accounts for a significant proportion of cases. This iteration of the global burden of liver disease is an update of the 2019 version and focuses mainly on areas where significant new information is available like alcohol-associated liver disease, non-alcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma. We also devote a separate section to the burden of liver disease in Africa, an area of the world typically neglected in such documents.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. J Hepatol. 2023. PMID: 36990226. doi:10.1016/j.jhep.2023.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。